PNC Financial Services Group
ACRS icon

PNC Financial Services Group’s Aclaris Therapeutics ACRS Stock Holding History

PNC Financial Services Group’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9K Sell
2,065
-5
-0.2% -$22 ﹤0.01% 4043
2026
Q1 		$7.76K Hold
2,070
– – ﹤0.01% 4063
2025
Q4 		$6.23K Buy
2,070
+31
+2% +$78 ﹤0.01% 4144
2025
Q3 		$3.87K Buy
+2,039
New +$3.56K ﹤0.01% 4303
2023
Q3 		– Sell
-912
Closed -$9.46K – 4607
2023
Q2 		$9.46K Buy
912
+186
+26% +$1.68K ﹤0.01% 3896
2023
Q1 		$5.87K Buy
+726
New +$9.21K ﹤0.01% 3984
2020
Q2 		– Sell
-84
Closed – – 3897
2020
Q1 		$0 Hold
84
– – ﹤0.01% 3871
2019
Q4 		$0 Hold
84
– – ﹤0.01% 3963
2019
Q3 		$0 Hold
84
– – ﹤0.01% 3972
2019
Q2 		$0 Hold
84
– – ﹤0.01% 3993
2019
Q1 		$0 Hold
84
– – ﹤0.01% 4011
2018
Q4 		$0 Hold
84
– – ﹤0.01% 4018
2018
Q3 		$2K Sell
84
-9,819
-99% -$168K ﹤0.01% 3929
2018
Q2 		$199K Buy
9,903
+1,835
+23% +$33.9K ﹤0.01% 2188
2018
Q1 		$142K Buy
8,068
+2
+0% +$42 ﹤0.01% 2364
2017
Q4 		$198K Buy
8,066
+166
+2% +$4.04K ﹤0.01% 2192
2017
Q3 		$204K Sell
7,900
-1,320
-14% -$35.4K ﹤0.01% 2133
2017
Q2 		$250K Buy
9,220
+1,900
+26% +$51.7K ﹤0.01% 2015
2017
Q1 		$218K Buy
7,320
+2,680
+58% +$77.3K ﹤0.01% 2079
2016
Q4 		$126K Buy
+4,640
New +$118K ﹤0.01% 2340

Other funds holding ACRS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

PNC Financial Services Group's ACRS Position: Q2 2026 in Review

PNC Financial Services Group reduced its Aclaris Therapeutics (ACRS) stake by 0.24% in Q2 2026, selling an estimated $22 and leaving 2,065 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4043.

PNC Financial Services Group first reported a position in ACRS in Q4 2016 and has held it in 20 quarters since. The position peaked at $250K in Q2 2017. 148 funds tracked by Wall St. Rank hold ACRS as of Q2 2026.

  • PNC Financial Services Group held 2,065 shares of Aclaris Therapeutics worth $10.9K as of Q2 2026.
  • PNC Financial Services Group sold 5 Aclaris Therapeutics shares in Q2 2026, an estimated $22.
  • Aclaris Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4043 holding.
  • PNC Financial Services Group first reported a position in Aclaris Therapeutics in Q4 2016 and has held it in 20 quarters since.
  • PNC Financial Services Group's Aclaris Therapeutics position peaked at $250K in Q2 2017.
  • 148 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.